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ON ANY given day, there are more people in nursing home beds than in acute-care hospital beds in the United States. Although nursing home resi-For editorial comment see p 3054. dents are among the most intensely medicated patients,1 little is known about the details of drug prescription and use in this large population of insti-tutionalized elderly persons. This arti¬ cle describes a large-scale study of all medication use in 850 residents of 12 representative Massachusetts nursing homes. It represents one of the few de¬ tailed surveys of medication use per¬ formed in the last decade with a large cohort of long-term-care residents. In programs.2 The report suggested seri¬ ous problems of overuse and misuse of drugs in this population. Patients were found to be taking an average of 6.1 drugs, and nearly 50% of all residents were prescribed tranquilizers (a catego¬ ry that included antipsychotic medica¬ tions and minor tranquilizers). Approxi¬ mately 12% of all residents were prescribed two or more psychoactive drugs, with antipsychotic medications prescribed much more often than minor tranquilizers. About one third of all patients were prescribed sedative/hyp¬ notics, and 9% were taking antidepressants. Of those receiving antidepressants, 38% were prescribed amitriptyline hydrochloride. In a more recent study reviewing Medicaid patients residing in nursing homes in Tennessee, Ray et al3 found that 42% ofthose patients received anti¬ psychotic medication. The authors con¬ cluded that their findings provided "epidemiologic evidence suggesting misuse of antipsychotic drugs in nursing homes." Further accounts of the over¬ use of psychoactive drugs in nursing homes were presented during widely 
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Health. Because the eventual goal was to provide an educational intervention, homes with fewer than 40 ICF-level res¬ idents were excluded. We identified 339 homes in Massachusetts that met this criterion; those in eastern Massachu¬ setts were considered for further study. Tb ensure that the homes represented typical geriatric facilities rather than those caring for deinstitutionalized mental hospital patients, homes were eliminated if they had greater than 20% of their residents admitted from inpatient psychiatric hospitals. Homes with active nurse practitioner prescribing were likewise excluded, as were facili¬ ties with preexisting relationships be¬ tween the authors and consulting phar¬ macists or physicians in the homes. The remaining 26 homes were given infor¬ mation about the drug-use interven¬ tion. Ten homes declined to participate in a randomized trial, primarily because of changes in ownership or administra¬ tion or labor disputes. Of the remaining 16 homes, 12 were enrolled in the study and four were retained as alternates on the basis of geographic distribution. A pilot survey of drug use over a twoweek period revealed no difference in average use of antipsychotic and seda¬ tive drugs between the study homes and the alternate homes.
Data Collection and Analysis
An interactive data collection pro¬ gram was written to guide research as¬ sistants in capturing medication-use data on a portable computer. In each facility, all medication data were re¬ corded for all residents for an entire month. For all drugs prescribed, the program prompted for data regarding medication name (trade or generic), current regimen, dosage changes, start and stop orders, route of administra¬ tion, and other changes in regimen dur¬ ing the month. A PRN use module made it possible to document the doses of PRN medications actually administered each day and sum them over the month. The software combined data on a given drug recorded as either its generic or trade name, as well as summing sched¬ uled doses and PRN doses actually ad¬ ministered. Additional programming made it possible to convert regimens into equivalent milligrams of a proto¬ type compound for each group (eg, chlorpromazine hydrochloride or diazepam), as well as analyze use by broad categories of drug (eg, all antipsychotic medication). In addition, the program also recorded the name of each patient's physician, the patient's age, sex, date of admission, payment source, current di¬ agnoses, and the date and reason for hospitalizations that occurred during the study period.
Data were collected regarding all pa¬ tients residing in the 12 study homes (n = 850). More than half (n = 441) of the study subjects were Medicaid patients. Because nursing homes rather than pa¬ tients were sampled, analyses were performed with the nursing home as the unit of analysis. In addition, to control for the potential influence of outlier fa¬ cilities and to make our results more generalizable to other ICFs, we mea¬ sured drug utilization as the median and interquartile range of the measures of drug use. This method is more conser¬ vative when there are significant interhome differences in specific usage cate¬ gories. To avoid considering drugs written for PRN use but not given, medications are described as having been "used" only if they were adminis¬ tered to the patient on at least five days in the study month. Nursing Homes Sampled Tb ensure that the homes studied were representative of ICFs through¬ out the state, we compared all available characteristics of each of the 339 Massa¬ chusetts ICFs that had 40 or more beds with those of the study homes, as indi¬ cated in Table 1 . The study homes were found to be quite similar to the universe of homes regarding patterns of owner¬ ship and management; as noted in Table  1 Table 2 shows that the homes studied were com¬ parable with all ICFs of similar size 
RESULTS

Demographics and Overall Drug Use
The total sample consisted of 850 pa¬ tients in 12 facilities; the median home had 70 patients, with an interquartile range of 60 to 80 patients. Unless other¬ wise stated, all results reported herein are the median of the 12 nursing home proportions or means; the interquartile ranges are indicated in parentheses.
As in most nursing home populations, the majority of residents, or 84% (range, 76% to 87%), were female; their mean age was 85 years (range, 84 to 96 years). Sixteen percent of patients were male, with a mean age of 82 years (range, 76 to 84 years). Of all drug or¬ ders written, 48% (n = 7168 orders; range, 37% to 52%) were written for PRN use.
The average number of different medications ordered per patient during the month was 8.1 (range, 7.4 to 8.8).
One fifth of all prescriptions were for over-the-counter analgesics and cathar¬ tics. Analysis of drugs actually given at least once each month and those given on at least five days each month demon¬ strated that patients received 5 Psychoactive Drug Use Nearly two thirds of the residents (65%; range, 58% to 71%) had orders written for one or more psychoactive medications, and 53% (range, 48% to 59%) actually used psychoactive drugs on five or more days during the study month (Table 3 ). These included seda¬ tive/hypnotics (including benzodiazepine tranquilizers), antipsychotics, and antidepressants. Barbiturates, antiseizure medications, antiparkinsonian drugs, lithium carbonate, and antihypertensives with known psychoactive properties were not included. Fortythree percent of orders (range, 35% to 48%) written for psychoactive drugs were written for PRN use, but only 20% of those PRN orders were used. There was no difference between Medicaid and non-Medicaid patients in overall psychoactive drug use or in any subcategoryofdruguse. About one fifth of patients (21%) had orders for two psychoactive medica¬ tions during the study month; 7% of pa¬ tients had orders for three or more psy¬ choactive medications. Actual use was somewhat less (Table 3 ).
Antipsychotic Drug Use
One third of patients (270) had orders written for antipsychotic medications. During the study month, 26% (range, 20.9% to 27.8%) of all residents actually used a neuroleptic on five or more days. Most of these patients had a combina¬ tion of scheduled neuroleptic prescrip¬ tions with additional PRN orders. Of all orders for antipsychotic medication written, 42% (range, 26 .6% to 45.5%) were for PRN use, and 58% for regular-ly scheduled regimens. However, only 11% (range, 0% to 17%) of PRN orders were activated during the study month. Of those patients taking antipsychotics, the median of the average daily dose by home was 65 mg per patient per day (range, 42 to 94 mg per patient per day) in milligram equivalents of chlorproma-zine20,21; for individual patients, the high¬ est dose observed was 2000 mg per day. Only 36 patients receiving antipsychotic medications carried a diagnosis of schizophrenia or other psychosis; Alz¬ heimer's disease, organic brain syn¬ drome, and depression were each more common diagnoses in these patients (Table 4 ).
Haloperidol was the most commonly prescribed antipsychotic medication and was given to 43% (range, 26% to 52%) of those receiving antipsychotics and to 10% ofthe total sample. Thioridazine hydrochloride was the second most commonly prescribed antipsychotic, given to 33% (range, 25% to 50%) of those receiving antipsychotics and to 7% (range, 6% to 14%) of the total population. Sedative/Hypnotic Drug Use Forty percent (range, 34% to 51%) of patients were prescribed sedative/hyp¬ notic drugs, and 28% (range, 23% to 41%) actually used these drugs for at least five days during the study month. Of these, 82% were receiving such a l medication on a regularly scheduled ba¬ sis. Most orders for minor tranquilizers and hypnotics were for regularly sched¬ uled use; while many patients had both scheduled and PRN orders, just 13% of patients prescribed sedative/hypnotics had only PRN orders. Twenty-three percent (range, 19% to 31%) of PRN orders for drugs in this class were used.
About one fourth (26%; range, 14% to 41%) of all patients receiving a seda¬ tive/hypnotic were prescribed diphenhydramine. Twenty percent (range, 11% to 25%) of all patients and 63% (range, 48% to 74%) of those receiving a sedative received a benzodiazepine. As with sedative/hypnotics in general, the majority of benzodiazepine orders were prescribed as a standing order (87%; range, 64% to 100%). Of those receiving benzodiazepines, 51 patients (30%; range, 15% to 39%) were taking the long-acting drugs flurazepam, diazepam, or chlordiazepoxide; for 67% of these patients, the regimen was a stand¬ ing order to be administered at least daily. The average consumption of ben¬ zodiazepines was 7.3 mg per patient per day (range, 6.7 to 9.5 mg per patient per day) in milligram equivalents of diazepam.20' 21' 22
Antidepressant Drug Use Fourteen percent (range, 10% to 17%) of patients used antidepressants.
These orders were written almost ex¬ clusively as regularly scheduled regi¬ mens, though two patients received the drug as a PRN bedtime hypnotic. There was no difference between men and women in overall use of antidepres¬ sants. While 47 (39%) ofthe 119 patients receiving antidepressants had a diagno¬ sis of depression recorded, the majority (61%) did not (Table 4 ).
Of those receiving antidepressants, the largest group (26%; range, 18% to 35%) received amitriptyline. The other antidepressants used were desipramine hydrochloride, doxepin hydrochloride, trazodone hydrochloride, imipramine hydrochloride, nortriptyline hydrochlo¬ ride, and maprotiline hydrochloride. COMMENT These data suggest that despite a growing literature on the risks of polypharmacy in elderly patients, total drug use has remained high in this sample of nursing homes. The Department of Health, Education, and Welfare Office of Long-Term Care study of 1976 found that nursing home residents had pre¬ scriptions for an average of 6.1 concur¬ rent medications per patient on the day of the survey. On average, patients in our study homes were prescribed 8.1 different medications during a month. Of these orders, an average of 4.7 drugs were actually used on five or more days by these residents. Though drugrelated adverse effects are well publi¬ cized and the seriousness ofsuch compli¬ cations are well known,6,22"25 those chronically institutionalized elderly pa¬ tients who are least able to cope with drug side effects appear to be at contin¬ ued risk for experiencing them.
The nursing homes from which these findings come are reasonably represen¬ tative of homes in Massachusetts and the Northeast in general. However, there are potential limits to the generalizability of these findings. We studied only intermediate-care patients. These are patients in need of less care than those admitted to skilled-nursing facili¬ ties, a selection criterion that would, if anything, tend toward lower medica¬ tion use. Facilities with high propor¬ tions of deinstitutionalized psychiatric patients were not included in the study.
On the other hand, the inclusion of all short-term drugs given during the study month (eg, antibiotics) somewhat increases the estimated number of drugs prescribed in comparison with the Department of Health, Education, and Welfare study, which was based on a single-day survey.
The use ofPRN medications presents special problems in nursing homes. Such orders place the responsibility of deciding to implement drug therapy on the nursing staff. It has been previously shown that extensive use of PRN medi¬ cation may adversely affect patient care26,27 if monitoring is poor and if the nursing staff is not adequately trained in the use and side effects of such drugs. Some authors have also suggested an increased cost to the institution when PRN orders are overused.27 The data presented herein document a very high level of PRN ordering of psychoactive medications, of concern in a level of care (ICF) with fewer requirements for the presence of skilled nursing surveillance. Nearly half of all orders for psychoac-tive drugs were written for PRN use. In practice, nurses initiated use of only about one fifth of these PRN orders.
Ironically, in those situations in which PRN use is generally preferred over regularly scheduled use (eg, as seda¬ tive/hypnotics), the data indicate that PRN use accounts for only a small frac¬ tion of drug administration.
In this study, over half of all patients were receiving psychoactive drugs; about one in four patients was taking two or more psychoactive medicines.
Reliance on scheduled regimens of psychoactive medicines indicates that these drugs are not used transiently for periods of special need. Instead, this pattern of use is compatible with the concept of sedation as "chemical restraint. "28 In many cases, the best drug within a therapeutic class was underutilized. This is exemplified by the high use of diphenhydramine as a hypnotic, a drug with strong anticholinergic properties9 that can lead to confusion and worsening of dementia, constipation, and urinary retention.18,29 Likewise, nearly one third of those who received benzodiazepines were prescribed older, long-acting drugs that are known to accumulate in elderly patients12,30,31 and are associated with a high frequency of toxic reactions in this age group.32 These findings differ from that of James,33 who found a level of use of hypnotics much lower than this study did, and lower than that reported in the rest of the literature. He attrib¬ uted this difference to more vigorous drug utilization review in the five facili¬ ties that agreed to participate in his survey.
Amitriptyline, the antidepressant with the highest anticholinergic and se¬ dating properties,10,34 and least favored for geriatric patients,35 was given to about one fourth ofthose taking an anti¬ depressant, despite the availability of medications less toxic for elderly pa¬ tients, such as the secondary amines. (This percentage of use is comparable with that reported in 1976, although the 1976 analysis ofthe Office of Long-Term Care considered perphenazine as an antidepressant, somewhat lowering the percentage of amitriptyline use.)
The usefulness of antipsychotic medi¬ cations in nonpsychotic, elderly pa¬ tients has been questioned,14"16 although these drugs represent a common ap¬ proach to the very difficult problem of managing disruptive behavior in de¬ mented patients who may be a risk to themselves or others. The high frequen¬ cy of toxic reactions to these drugs is well documented, with many older pa¬ tients who take them experiencing orthostatic hypotension, Parkinson's syn-drome, tardive dyskinesia, akathisia, worsened confusion, dry mouth, consti¬ pation, oversedation, and urinary in¬ continence.1832,3637 Although the total use of these drugs in this study is slightly lower than that in earlier reports, previ¬ ous studies included many chronically institutionalized psychotic patients, es¬ timated to make up at least 8% of all nursing home residents3839; these pa¬ tients were in large part excluded from our sample.
These findings indicate that there is References need for considerably more effort to im¬ prove the use of psychoactive drugs in institutionalized elderly patients. Psy¬ choactive medications continue to be used with high frequency and selection of drug is often suboptimal. Further analysis is required of the factors that influence drug use in nursing homes. Many of these may represent problems of inadequate staffing as well as infor¬ mation deficits among prescribers. There is a pressing need to study the clinical impact of such high levels of psy-choactive drug use in this population to determine whether more judicious use of medications would result in reduced levels of disability in these already im¬ paired elderly patients.
